HAWAII BIOTECH, INC.

Basic Information

99-193 AIEA HEIGHTS DRIVE, SUITE 200
AIEA, HI, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 113226823
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Novel Adjuvants to Enhance the Immunogenicity of a Dengue Vaccine

    Amount: $99,888.00

    Dengue virus (DENV) is a mosquito-borne flavivirus that poses a tremendous public health threat throughout the world. The U.S. military has also been challenged by dengue for over a hundred years and ...

    SBIR Phase I 2015 Department of DefenseArmyDepartment of Defense
  2. Development of a Recombinant Subunit Vaccine for CCHF

    Amount: $530,899.00

    DESCRIPTION (provided by applicant): Emerging and reemerging infectious diseases continue to pose serious health threats world-wide. Consequently, the development of measures to mitigate the natural, ...

    SBIR Phase I 2012 Department of Health and Human Services
  3. Recombinant Subunit Vaccine For Tick-Borne Encephalitis

    Amount: $2,983,509.00

    DESCRIPTION (provided by applicant): Tick-borne encephalitis (TBE) is a neurological disease caused by Flaviviruses of the tick-borne encephalitis group and causes death in up to 60% of the individua ...

    SBIR Phase II 2009 Department of Health and Human Services
  4. Discovery of West Nile Virus Protease Inhibitors

    Amount: $999,975.00

    DESCRIPTION (provided by applicant): The strain of West Nile virus now endemic in the continental United States is more virulent than the virus originally isolated in Africa and is classified as a cat ...

    SBIR Phase I 2006 Department of Health and Human Services
  5. Structure Based Design of Dengue Virus Fusion Inhibitors

    Amount: $797,650.00

    DESCRIPTION (provided by applicant): Over half of the world population is at risk for infection by dengue virus, a mosquito borne member of the Flavivirus family that consists of four distinct serotyp ...

    SBIR Phase I 2006 Department of Health and Human Services
  6. Optimization of Small Molecule Botulinum Neurotoxin Inhibitors

    Amount: $1,019,214.00

    DESCRIPTION (provided by applicant): Medicinal and computational chemistry methods will be used to optimize validated hit compounds found to inhibit botulinum neurotoxin. These inhibitors, discovered ...

    SBIR Phase I 2006 Department of Health and Human Services
  7. Recombinant Subunit Protein for Flu Vaccine

    Amount: $979,908.00

    DESCRIPTION (provided by applicant): Current influenza vaccine production procedures (use of embryonated chicken eggs) inherently limit the amount of influenza vaccine that can be produced prior to e ...

    SBIR Phase I 2005 Department of Health and Human Services
  8. Recombinant Subunit Vaccine/Prevention of West Nile Vir*

    Amount: $5,046,576.00

    DESCRIPTION (provided by applicant): West Nile virus infection is an emerging infectious disease in the United States. The virus infects birds, which serve as the natural reservoir for the virus, in a ...

    SBIR Phase II 2004 Department of Health and Human Services
  9. Recombinant Subunit Vaccine for Tick-Borne Encephalitis

    Amount: $422,170.00

    DESCRIPTION (provided by applicant): Tick-borne encephalitis (TBE) is a neurological disease caused by Flaviviruses of the tick-borne encephalitis group and causes death in up to 60% of the individua ...

    SBIR Phase I 2004 Department of Health and Human Services
  10. Development of a Subunit Vaccine for West Nile

    Amount: $189,420.00

    DESCRIPTION (provided by applicant): West Nile virus infection has become an emerging infectious disease in the United States. The virus infects birds, the natural reservoir of the virus, and is tran ...

    SBIR Phase I 2003 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government